Impetus Digital

APRIL 24, 2023

Healthcare providers (HCPs), payers, and patients can now access medical information at their fingertips and they expect more from Pharma than in the past. This offers new opportunities to engage with stakeholders beyond just physicians. In 2023, we will see MA engage both patients and payers more than in previous years.

Medical 52

Medical Education Physicians Healthcare 52

Clarity Engagement Solutions

NOVEMBER 9, 2020

The primary purpose of Medical Science Liaison MSL is to establish and maintain peer-peer relationships with leading physicians, referred to as Key Opinion Leaders KOL’s, at major academic institutions and clinics. Asking strategic questions leads to a better understanding of medical practices and habits.

Education 91

Education Medical science Medical Pharma 91

PM360

AUGUST 29, 2022

1 EHRs have become the primary means for registering and seeing patients, making and documenting diagnoses, prescribing treatments, and implementing follow up, all in the pursuit of improving outcomes (both clinical and economic) and the user experience in healthcare. First, finding patients missing a specific immunization.

Electronics 97

Electronics Patients Medical Healthcare 97

Veeva

FEBRUARY 6, 2022

This engagement is continuing to remain high, with evolving requirements and preferences of healthcare practitioners (HCPs) in the ways they engage with pharma reps and medical science liaisons (MSLs) through virtual communications. Five steps to closing the CX gap with HCPs and Patients. Get stakeholder buy in on the “why”.

Pharma 52

Pharma Medical Consulting Pharma reps 52

Pharmaceutical Technology

NOVEMBER 2, 2022

With this comes new hope for previously underserved patient populations. But educating the world of physicians about these new medicines and collaborating with healthcare professionals on trials and other important initiatives is critical to their commercial success. Expanding horizons.

Medical 52

Medical Medicine Pharma Networking 52

Evolve Your Success

DECEMBER 19, 2023

Career success in MedTech is not just about climbing the corporate ladder; it’s about relentlessly advocating for patients, embracing change, and, above all, never giving up. I am a person who has devoted his life to medical technology. We need to bring innovative new therapies to the market and the patients.

Engineering 52

Engineering Patients Medical Sales 52

Rep-Lite

JANUARY 11, 2024

They have to meet with doctors, nurses, and healthcare administrators to whom they will have to present products, conduct demonstrations, and discuss patient needs and how offering meets them. Medical Education Specialist: Create CME/CE-accredited training on medical products for physicians.

Sales 52

Sales Healthcare Healthcare Medical sales 52

Evolve Your Success

OCTOBER 31, 2023

Neuromodulation isn’t just about stimulating nerves; it’s about awakening hope and transforming lives—one patient at a time. In this episode, Blake Williams takes us on a wild journey through his career as a Field Clinical Engineer (FCE), shedding light on the incredible impact of neuromodulation on the lives of patients.

Engineering 52

Engineering Sales Medical sales Physicians 52

PM360

APRIL 22, 2024

Medical science Liaisons know that change is coming; How are they cashing in? Medical science liaisons (MSLs) within pharmaceutical companies deal in a special currency: scientific exchange and real-world insights gathering.

Education 52

Education Customer Relationship Management Medical science Medical 52

Clarify Health

MAY 19, 2020

The time-consuming and resource-intensive path from the lab bench to the patient bedside starts with drug discovery, progresses to pre-clinical and clinical research, and then enters regulatory review. Any misstep in terms of pricing, reimbursement, or marketing could mean delays in providing therapies to the patients who need them most.

Biopharma 52

Biopharma Physicians Marketing Prescription 52

Pharmaceutical Technology

NOVEMBER 21, 2022

Manufacturing woes have affected both cell and gene-modified cell therapies in oncology recently, disadvantaging patients with multiple myeloma (MM) and melanoma. DELTA-1 is a Phase II single-arm trial in metastatic melanoma, evaluating the efficacy of ITIL-168 in patients who have progressed on previous therapy.

Manufacturing 59

Manufacturing Food and Drug Administration Medical science Patients 59

Medgadget

FEBRUARY 17, 2023

All of these systems operate under the “master-slave” concept, which involves a surgeon sitting behind a console, away from the patient, who manipulates the mechanical arms of the robot via some kind of joystick-like device. are still done in an open fashion.

Physicians 80

Physicians Engineering Side effects Leads 80

Medgadget

MARCH 22, 2023

Cancer therapies have proliferated over the past few decades, improving outcomes for many patients. Dean recounted how only two decades ago we only had access to one-size-fits-all treatments that were effective for some patients, but did nothing for others.

Patients 79

Patients Medical science Leads Medical 79

PM360

DECEMBER 20, 2023

A series of studies and surveys have documented the fact that substantial numbers of physicians, nurses, and allied health professionals are active on or prefer social media for professional purposes and to connect directly with peers. A majority of HCPs want to receive relevant information on their own times and terms.

Media 122

Media Physicians Pharma reps Pharma Rep 122

Medgadget

MARCH 2, 2023

To make implantation of the Alpha DaRT sources easy and precise, the company developed dedicated applicators andadapted existing biopsy devices, that physicians are already acquainted with, to deliver the radioactive sources. The rest of the patients had partial responses. with ten patients to try to duplicate the results.

Manufacturing 83

Manufacturing Leads Patients Medicine 83